(Q43505391)

English

Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34.

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

5

object named as

Shibo Jiang

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Lai-Xi Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Haijing Song

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Shuwen Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Hong Lu

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Jiahong Ni

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Hengguang Li

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1068-1074

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Role of gp41 glycosylation sites in the biological activity of human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

A general approach to the synthesis of O- and N-linked glycopeptides.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Homogeneous glycopeptides and glycoproteins for biological investigation.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Toward automated synthesis of oligosaccharides and glycoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

In pursuit of carbohydrate-based HIV vaccines, part 1: The total synthesis of hybrid-type gp120 fragments

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

In pursuit of carbohydrate-based HIV vaccines, part 2: The total synthesis of high-mannose-type gp120 fragments--evaluation of strategies directed to maximal convergence

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Synthesis of neoglycoconjugates by transglycosylation with Arthrobacter protophormiae endo-beta-N-acetylglucosaminidase. Demonstration of a macro-cluster effect for mannose-binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Probing the effect of the outer saccharide residues of N-linked glycans on peptide conformation

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Targeting FOXO kills two birds with one stone

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Synthesis and anti-HIV-1 activity of 4-[4-(4,6-bisphenylamino-triazin-2-ylamino)-5-methoxy-2-methylphenylazo]-5-hydroxynaphthalene-2,7-disulfonic acid and its derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Identifying epitopes of HIV-1 that induce protective antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

HIV vaccine design and the neutralizing antibody problem

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200400440

21 January 2018

Identifiers

10.1002/CBIC.200400440

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43505391&oldid=1614039918"